Kite Pharma (KITE) Jumps as Drug Trials Resume

Kite Pharma Inc (NASDAQ: KITE) rose 5.9% to $49.72 following news of Juno Therapeutics’ drug trial resuming. Share volume was 1.4 million, compared to an all-day average of 858,000